Cargando…

Tumour‐specific and organ‐specific protein synthesis rates in patients with pancreatic cancer

BACKGROUND: Living tissues maintain a fine balance between protein synthesis and protein breakdown rates. Animal studies indicate that protein synthesis rates are higher in organs when compared with skeletal muscle tissue. As such, organ and tumour protein synthesis could have major effects on whole...

Descripción completa

Detalles Bibliográficos
Autores principales: van Dijk, David P.J., Horstman, Astrid M.H., Smeets, Joey S.J., den Dulk, Marcel, Grabsch, Heike I., Dejong, Cornelis H.C., Rensen, Sander S., Olde Damink, Steven W.M., van Loon, Luc J.C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6596396/
https://www.ncbi.nlm.nih.gov/pubmed/30868736
http://dx.doi.org/10.1002/jcsm.12419
_version_ 1783430503702986752
author van Dijk, David P.J.
Horstman, Astrid M.H.
Smeets, Joey S.J.
den Dulk, Marcel
Grabsch, Heike I.
Dejong, Cornelis H.C.
Rensen, Sander S.
Olde Damink, Steven W.M.
van Loon, Luc J.C.
author_facet van Dijk, David P.J.
Horstman, Astrid M.H.
Smeets, Joey S.J.
den Dulk, Marcel
Grabsch, Heike I.
Dejong, Cornelis H.C.
Rensen, Sander S.
Olde Damink, Steven W.M.
van Loon, Luc J.C.
author_sort van Dijk, David P.J.
collection PubMed
description BACKGROUND: Living tissues maintain a fine balance between protein synthesis and protein breakdown rates. Animal studies indicate that protein synthesis rates are higher in organs when compared with skeletal muscle tissue. As such, organ and tumour protein synthesis could have major effects on whole‐body protein metabolism in wasting disorders such as cancer cachexia. We aimed to assess protein synthesis rates in pancreatic tumour tissue and healthy pancreas, liver, and skeletal muscle tissue in vivo in humans. METHODS: In eight patients with pancreatic cancer undergoing pancreaticoduodenectomy, primed continuous infusions with L‐[ring‐(13)C(6)]phenylalanine and L‐[3,5‐(2)H(2)]tyrosine were started prior to surgery and continued throughout the surgical procedures. During surgery, plasma samples and biopsies from the pancreas, pancreatic tumour, liver, and vastus lateralis muscle were taken. Post‐absorptive fractional protein synthesis rates were determined by measuring incorporation of labelled L‐[ring‐(13)C(6)]phenylalanine in tissue protein using the weighed plasma L‐[ring‐(13)C(6)]phenylalanine enrichments as the precursor pool. RESULTS: Five male patients and three female patients with a mean age of 67 ± 2 years were included into this study. Plasma L‐[ring‐(13)C(6)]phenylalanine enrichments (6–9 mole per cent excess) did not change during surgery (P = 0.60). Pancreatic tumour protein synthesis rates were 2.6‐fold lower than surrounding pancreatic tissue protein synthesis rates (0.268 ± 0.053 vs. 0.694 ± 0.228%/h, respectively; P = 0.028) and 1.7‐fold lower than liver protein synthesis rates (0.268 ± 0.053 vs. 0.448 ± 0.043%/h, respectively; P = 0.046). Among healthy organ samples, protein synthesis rates were 20‐fold and 13‐fold higher in pancreas and liver, respectively, compared with skeletal muscle tissue (0.694 ± 0.228 and 0.448 ± 0.043 vs. 0.035 ± 0.005%/h, respectively; P < 0.05). CONCLUSIONS: Liver and pancreas tissue protein synthesis rates are higher when compared with pancreatic tumour and skeletal muscle tissue protein synthesis rates and can, therefore, strongly impact whole‐body protein metabolism in vivo in humans.
format Online
Article
Text
id pubmed-6596396
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-65963962019-07-11 Tumour‐specific and organ‐specific protein synthesis rates in patients with pancreatic cancer van Dijk, David P.J. Horstman, Astrid M.H. Smeets, Joey S.J. den Dulk, Marcel Grabsch, Heike I. Dejong, Cornelis H.C. Rensen, Sander S. Olde Damink, Steven W.M. van Loon, Luc J.C. J Cachexia Sarcopenia Muscle Original Articles BACKGROUND: Living tissues maintain a fine balance between protein synthesis and protein breakdown rates. Animal studies indicate that protein synthesis rates are higher in organs when compared with skeletal muscle tissue. As such, organ and tumour protein synthesis could have major effects on whole‐body protein metabolism in wasting disorders such as cancer cachexia. We aimed to assess protein synthesis rates in pancreatic tumour tissue and healthy pancreas, liver, and skeletal muscle tissue in vivo in humans. METHODS: In eight patients with pancreatic cancer undergoing pancreaticoduodenectomy, primed continuous infusions with L‐[ring‐(13)C(6)]phenylalanine and L‐[3,5‐(2)H(2)]tyrosine were started prior to surgery and continued throughout the surgical procedures. During surgery, plasma samples and biopsies from the pancreas, pancreatic tumour, liver, and vastus lateralis muscle were taken. Post‐absorptive fractional protein synthesis rates were determined by measuring incorporation of labelled L‐[ring‐(13)C(6)]phenylalanine in tissue protein using the weighed plasma L‐[ring‐(13)C(6)]phenylalanine enrichments as the precursor pool. RESULTS: Five male patients and three female patients with a mean age of 67 ± 2 years were included into this study. Plasma L‐[ring‐(13)C(6)]phenylalanine enrichments (6–9 mole per cent excess) did not change during surgery (P = 0.60). Pancreatic tumour protein synthesis rates were 2.6‐fold lower than surrounding pancreatic tissue protein synthesis rates (0.268 ± 0.053 vs. 0.694 ± 0.228%/h, respectively; P = 0.028) and 1.7‐fold lower than liver protein synthesis rates (0.268 ± 0.053 vs. 0.448 ± 0.043%/h, respectively; P = 0.046). Among healthy organ samples, protein synthesis rates were 20‐fold and 13‐fold higher in pancreas and liver, respectively, compared with skeletal muscle tissue (0.694 ± 0.228 and 0.448 ± 0.043 vs. 0.035 ± 0.005%/h, respectively; P < 0.05). CONCLUSIONS: Liver and pancreas tissue protein synthesis rates are higher when compared with pancreatic tumour and skeletal muscle tissue protein synthesis rates and can, therefore, strongly impact whole‐body protein metabolism in vivo in humans. John Wiley and Sons Inc. 2019-03-13 2019-06 /pmc/articles/PMC6596396/ /pubmed/30868736 http://dx.doi.org/10.1002/jcsm.12419 Text en © 2019 The Authors. Journal of Cachexia, Sarcopenia and Muscle published by John Wiley & Sons Ltd on behalf of the Society on Sarcopenia, Cachexia and Wasting Disorders This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
spellingShingle Original Articles
van Dijk, David P.J.
Horstman, Astrid M.H.
Smeets, Joey S.J.
den Dulk, Marcel
Grabsch, Heike I.
Dejong, Cornelis H.C.
Rensen, Sander S.
Olde Damink, Steven W.M.
van Loon, Luc J.C.
Tumour‐specific and organ‐specific protein synthesis rates in patients with pancreatic cancer
title Tumour‐specific and organ‐specific protein synthesis rates in patients with pancreatic cancer
title_full Tumour‐specific and organ‐specific protein synthesis rates in patients with pancreatic cancer
title_fullStr Tumour‐specific and organ‐specific protein synthesis rates in patients with pancreatic cancer
title_full_unstemmed Tumour‐specific and organ‐specific protein synthesis rates in patients with pancreatic cancer
title_short Tumour‐specific and organ‐specific protein synthesis rates in patients with pancreatic cancer
title_sort tumour‐specific and organ‐specific protein synthesis rates in patients with pancreatic cancer
topic Original Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6596396/
https://www.ncbi.nlm.nih.gov/pubmed/30868736
http://dx.doi.org/10.1002/jcsm.12419
work_keys_str_mv AT vandijkdavidpj tumourspecificandorganspecificproteinsynthesisratesinpatientswithpancreaticcancer
AT horstmanastridmh tumourspecificandorganspecificproteinsynthesisratesinpatientswithpancreaticcancer
AT smeetsjoeysj tumourspecificandorganspecificproteinsynthesisratesinpatientswithpancreaticcancer
AT dendulkmarcel tumourspecificandorganspecificproteinsynthesisratesinpatientswithpancreaticcancer
AT grabschheikei tumourspecificandorganspecificproteinsynthesisratesinpatientswithpancreaticcancer
AT dejongcornelishc tumourspecificandorganspecificproteinsynthesisratesinpatientswithpancreaticcancer
AT rensensanders tumourspecificandorganspecificproteinsynthesisratesinpatientswithpancreaticcancer
AT oldedaminkstevenwm tumourspecificandorganspecificproteinsynthesisratesinpatientswithpancreaticcancer
AT vanloonlucjc tumourspecificandorganspecificproteinsynthesisratesinpatientswithpancreaticcancer